Copper Cu-64 Dotatate Patent Expiration
Copper Cu-64 Dotatate is Used for localizing somatostatin receptor positive neuroendocrine tumors in adult patients. It was first introduced by Radiomedix Inc
Copper Cu-64 Dotatate Patents
Given below is the list of patents protecting Copper Cu-64 Dotatate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Detectnet | US12102696 | Radiolabeling and formulation for scale up of 64Cu-DOTATATE | Sep 03, 2041 | Radiomedix |
| Detectnet | US10159759 | Pet tracer for imaging of neuroendocrine tumors | Aug 23, 2032 | Radiomedix |
| Detectnet | US10383961 | PET tracer for imaging of neuroendocrine tumors | Aug 23, 2032 | Radiomedix |
| Detectnet | US11160888 | PET tracer for imaging of neuroendocrine tumors | Aug 23, 2032 | Radiomedix |
Copper Cu-64 Dotatate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List